Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2014
09/30/2014US8846622 Targeted delivery of botulinum toxin to the sphenopalatine ganglion
09/30/2014US8846621 Compositions and methods for treating diseases associated with angiogenesis and inflammation
09/30/2014US8846620 Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
09/30/2014US8846619 Artificial oxygen transport protein
09/30/2014US8846618 Stable formulation of modified GLP-1
09/30/2014US8846617 Inflammation inhibiting compounds
09/30/2014US8846616 Alpha-melanocyte stimulating hormone as topical anti-inflammatory agent for the treatment of allergic contact dermatitis and eczema
09/30/2014US8846615 MNTF peptides
09/30/2014US8846614 Process for the synthesis of 37-mer peptide pramlintide
09/30/2014US8846612 Promotion of healthy catch-up growth
09/30/2014US8846611 Skin conditions using human growth hormone
09/30/2014US8846610 Methods for preparing purified lipopeptides
09/30/2014US8846609 Leukotoxin E/D as a new anti-inflammatory agent and microbicide
09/30/2014US8846608 Human lactoferrin derived peptides and their use
09/30/2014US8846607 Particles for treatment of pulmonary infection
09/30/2014US8846605 Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
09/30/2014US8846601 Melanocortin receptor-specific peptides
09/30/2014US8846578 Zinc finger nuclease for the CFTR gene and methods of use thereof
09/30/2014US8846394 Treatment of neurological deficits in the striatum or substanta nigra pars compacta
09/30/2014US8846392 Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration
09/30/2014US8846386 sVEGFR-2 and its role in lymphangiogenesis modulation
09/30/2014US8846363 Compositions of and methods of using sulfatases from Flavobacterium heparinum
09/30/2014US8846361 Solid phytase compositions stabilized with corn steep liquor
09/30/2014US8846354 Microorganisms for producing organic acids
09/30/2014US8846345 Recombinant cell line
09/30/2014US8846344 Process for the purification of glycoproteins
09/30/2014US8846306 Use of a globin, a globin protomer or an extracellular hemoglobin obtained from the marine worm, Arenicola marina, for the preservation of organs, tissues, cells or cell cultures
09/30/2014US8846118 Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
09/30/2014US8846105 Dry powder fibrin sealant
09/30/2014US8846099 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
09/30/2014US8846098 Artificial cell constructs for cellular manipulation
09/30/2014US8846082 Probiotic and preservative uses of oil-emulsified probiotic encapsulations
09/30/2014US8846064 Cosmetic and pharmaceutical compositions having modified proteins in the form of a supramolecular assembly
09/30/2014US8846046 Low dose methods for treating disorders in which TNFα activity is detrimental
09/30/2014US8846036 Antibodies that bind to mammalian NGAL and uses thereof
09/30/2014US8846034 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
09/30/2014US8846033 Dietary supplement
09/30/2014US8846030 Compounds and methods to enhance rAAV transduction
09/30/2014US8846026 Composition comprising immunogenic microparticles
09/30/2014US8846025 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
09/30/2014US8846024 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
09/30/2014US8846023 Hepatitis C virus inhibitors
09/30/2014US8846003 Collagen-binding synthetic peptidoglycans, preparation, and methods of use
09/30/2014CA2670964C Use of composition for manufacture of medicant and method for inhibiting formation of body fat
09/30/2014CA2617133C Compositions and methods for treating bacteria
09/30/2014CA2506737C Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll)
09/30/2014CA2356706C Novel exendin agonist formulations and methods of administration thereof
09/30/2014CA2252439C Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
09/25/2014WO2014153385A2 Methods of treating metabolic disorders
09/25/2014WO2014153241A1 Treatment of staphylococcal disorders
09/25/2014WO2014153221A2 Acth for treatment of acute respiratory distress syndrome
09/25/2014WO2014153044A1 Treatment of patients with hyponatremia and cardiac disease
09/25/2014WO2014153038A1 Biocompatible hydrogel polymer matrix for delivery of cells
09/25/2014WO2014152971A2 Modulation of angiogenesis and related conditions using inhibitors of g-protein-coupled receptor kinase interacting protein-1 (git1)
09/25/2014WO2014152955A1 Apelin fusion proteins and uses thereof
09/25/2014WO2014152831A2 Targeting peptides and uses thereof
09/25/2014WO2014152776A1 Apolipoprotein mimetics and uses thereof
09/25/2014WO2014152751A1 Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies
09/25/2014WO2014152629A1 Combination therapy to improve soft tissue healing, fat graft healing, endochondral bone healing and osteointegration
09/25/2014WO2014152530A1 Variant factor viii polypeptides and methods of their production and use
09/25/2014WO2014152511A1 Methods for promoting wound healing and hair growth
09/25/2014WO2014152497A2 Osteocalcin as a treatment for cognitive disorders
09/25/2014WO2014152460A2 Prodrugs with prolonged action
09/25/2014WO2014152437A2 Methods of use for an antimicrobial peptide
09/25/2014WO2014152391A1 Cell-penetrating compstatin analogs and uses thereof
09/25/2014WO2014152195A1 Il-33 antagonists and uses thereof
09/25/2014WO2014152090A1 Compositions and treatments of metabolic disorders using fgf binding protein 3 and fgf 19
09/25/2014WO2014152089A1 Compositions and treatments of metabolic disorders using fgf binding protein 3
09/25/2014WO2014151982A2 Arginine deiminase with reduced cross-reactivity toward adi – peg 20 antibodies for cancer treatment
09/25/2014WO2014151968A1 Subcutaneous administration of adamts13
09/25/2014WO2014151962A1 Method of treating metabolic disorders using pla2g12a polypeptides and pla2g12a mutant polypeptides
09/25/2014WO2014151931A1 Systems for selectively migrating cells using electric fields
09/25/2014WO2014151923A1 Factor h for treatment of rheumatoid arthritis
09/25/2014WO2014151919A1 Factor h for transplantation
09/25/2014WO2014151747A1 Methods and compositions with immune therapy for treatment of dementia
09/25/2014WO2014151725A1 Composition of a sustained-release delivery and method of stabilizing proteins during fabrication process
09/25/2014WO2014151705A1 Methods for preparing injectable protein microparticle suspensions
09/25/2014WO2014151634A1 Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
09/25/2014WO2014151381A1 Bioerodible silicon-based compositions for delivery of therapeutic agents
09/25/2014WO2014151369A2 Stabilized ezh2 peptides
09/25/2014WO2014151338A1 Methods for treating multiple sclerosis
09/25/2014WO2014151206A1 Agonists of guanylate cyclase and their uses
09/25/2014WO2014151200A2 Compositions useful for the treatment of gastrointestinal disorders
09/25/2014WO2014151107A1 Wound healing compositions
09/25/2014WO2014151011A1 Selective inhibitor of angiotensin ii
09/25/2014WO2014150748A2 Stabilized single human cd4 domains and fusion proteins
09/25/2014WO2014150571A1 Reducing proinflammatory response
09/25/2014WO2014150566A1 Reducing the risk of autoimmune disease
09/25/2014WO2014150563A1 Activating adiponectin by casein hydrolysate
09/25/2014WO2014150558A1 Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
09/25/2014WO2014150557A1 Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
09/25/2014WO2014150556A1 Nutritional compositions containing a peptide component and uses thereof
09/25/2014WO2014150477A1 Recombinant factor viii formulations
09/25/2014WO2014150413A1 Compositions and methods for the treatment of carboxyhemoglobinemia
09/25/2014WO2014149985A1 Cellulase and phytase inhibitor
09/25/2014WO2014149979A1 Treatment of peripheral vascular disease using protein solutions
09/25/2014WO2014149699A1 Bifunctional protein
09/25/2014WO2014149301A1 Methods and non-immunogenic compositions for treating inflammatory disorders
09/25/2014WO2014149300A1 Treatment of inflammatory respiratory disease using biological solutions
09/25/2014WO2014149270A1 Treatment of pain using protein solutions
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 3163